Mario Calvitti

Mario Calvitti

Auto-generated profile, based on publicly available information

Mario Calvitti

Department of Experimental Medicine, University of Perugia, Perugia, Italy

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2011 in Nature Immunology
Verified
Journal Article
Closed access
MPMaria Teresa Pallotta
Maria Teresa Pallotta
COCiriana Orabona
Ciriana Orabona
CVClaudia Volpi
Claudia Volpi
CVCarmine Vacca
Carmine Vacca
MBMaria Laura Belladonna
Maria Laura Belladonna
UGUrsula Grohmann
Ursula Grohmann

27 September 2005 in Transplantation
Verified
Journal Article
Closed access
LPLaura Pierdomenico
Laura Pierdomenico
LBLaura Bonsi
Laura Bonsi
MCMario Calvitti
Mario Calvitti
DRDamiano Rondelli
Damiano Rondelli
MAMario Arpinati
Mario Arpinati
GBGian Paolo Bagnara
Gian Paolo Bagnara
Bone marrow mesenchymal stem cells (MSCs) are currently being investigated in preclinical and clinical settings because of their multipotent differentiative capacity or, alternatively, their immunosuppressive function. The aim of this study was to evaluate dental pulp (DP) as a potential source of MSCs instead of bone marrow (BM). Flow cytometric analysis showed that DP-MSCs and BM-MSCs were equally SH2, SH3, SH4, CD29 and CD 166 positive. The in vitro proliferative kinetics of MSCs were measured by 3H-thymidine incorporation uptake. The immunosuppressive function of MSCs was then tested by coculturing PHA-stimulated allogeneic T cells with or without MSCs for 3 days. BM-MSCs could be differentiated in vitro into osteogenic, chondrogenic and adipogenic lineages. DP-MSCs showed osteogenic and adipocytic differentiation, but did not differentiate into chondrocytes. Although DP-MSCs grow rapidly in vitro between day 3 and day 8 of culture and then decrease their proliferation by day 15, BM-MSCs have a stable and continuous proliferation over the same period of time. The addition of DP-MSCs or BM-MSCs resulted in 91 ± 4% and 75 ± 3% inhibition of T cell response, respectively, assessed by a 3H-thymidine assay. Dental pulp is an easily accessible and efficient source of MSCs, with different kinetics and differentiation potentialities from MSCs as isolated from the bone marrow. The rapid proliferative capacity together with the immunoregulatory characteristics of DP-MSCs may prompt future studies aimed at using these cells in the treatment or prevention of T-cell alloreactivity in hematopoietic or solid organ allogeneic transplantation.

15 November 2006 in Blood
Verified
Journal Article
Closed access
PDF file
SBSilvia Bozza
Silvia Bozza
FBFrancesco Bistoni
Francesco Bistoni
Roberta GazianoRoberta Gaziano
Roberta Gaziano
LPLucia Pitzurra
Lucia Pitzurra
TERESA ZELANTETERESA ZELANTE
TERESA ZELANTE
LRLuigina Romani
Luigina Romani
Reactivation of latent human cytomegalovirus (HCMV) following allogeneic transplantation is a major cause of morbidity and mortality and predisposes to severe complications, including superinfection by Aspergillus species (spp). Antimicrobial polypeptides, including defensins and mannan-binding lectin, are known to block viral fusion by cross-linking sugars on cell surface. Pentraxin 3 (PTX3), a member of the long pentraxin family, successfully restored antifungal immunity in experimental hematopoietic transplantation. We assessed here whether PTX3 binds HCMV and murine virus (MCMV) and the impact on viral infectivity and superinfection in vivo. We found that PTX3 bound both viruses, reduced viral entry and infectivity in vitro, and protected from MCMV primary infection and reactivation as well as Aspergillus superinfection. This occurred through the activation of interferon (IFN) regulatory factor 3 (IRF3) in dendritic cells via the TLR9/MyD88-independent viral recognition sensing and the promotion of the interleukin-12 (IL-12)/IFN-γ–dependent effector pathway.

1 February 2005 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
SBSilvia Bellocchio
Silvia Bellocchio
Roberta GazianoRoberta Gaziano
Roberta Gaziano
SBSilvia Bozza
Silvia Bozza
GRGiordano Rossi
Giordano Rossi
CMClaudia Montagnoli
Claudia Montagnoli
LRLuigina Romani
Luigina Romani
Objectives: Neutrophils play a crucial role in the control of the Aspergillus fumigatus infection and act in concert with antifungal drugs. This study was undertaken to obtain insights into the possible involvement of Toll-like receptors (TLRs) in the interaction of liposomal amphotericin B (L-AmB; AmBisome) with neutrophils in response to A. fumigatus. Methods: For generation of bone marrow-transplanted mice, irradiated C57BL6 mice were infused with T cell-depleted allogeneic donor cells. For infection, mice were injected intranasally with Aspergillus fumigatus conidia and treated with L-Amb and deoxycholate amphotericin B prophylactically or therapeutically. For TLR-dependent antifungal functions, murine neutrophils were preincubated with antifungals or TLR ligands before the addition of Aspergillus conidia. Results: The results show that: (a) neutrophil activation by Aspergillus occurs through TLR signalling pathways differently affecting the oxidative and non-oxidative mechanisms of the killing machinery; (b) by diverting signalling from TLR-2 to TLR-4, liposomes of AmBisome activate neutrophils to an antifungal state while attenuating the pro-inflammatory effects of deoxycholate amphotericin B; (c) this translates in vivo to the optimization of the AmBisome therapeutic efficacy in mice with aspergillosis. Conclusions: These results provide a putative molecular basis for the reduced infusion-related toxicity of AmBisome and suggest that TLR manipulation in vivo is amenable to the induction of optimal microbicidal activity in the absence of inflammatory cytotoxicity to host cells.

12 October 2009 in Journal of Experimental Medicine
Verified
Journal Article
Open access
Francesca FallarinoFrancesca Fallarino
Francesca Fallarino
GLGiovanni Luca
Giovanni Luca
MCMario Calvitti
Mario Calvitti
FMFrancesca Mancuso
Francesca Mancuso
Claudio NastruzziClaudio Nastruzzi
Claudio Nastruzzi
RCRiccardo Calafiore
Riccardo Calafiore
Type I diabetes mellitus is caused by autoimmune destruction of pancreatic β cells, and effective treatment of the disease might require rescuing β cell function in a context of reinstalled immune tolerance. Sertoli cells (SCs) are found in the testes, where their main task is to provide local immunological protection and nourishment to developing germ cells. SCs engraft, self-protect, and coprotect allogeneic and xenogeneic grafts from immune destruction in different experimental settings. SCs have also been successfully implanted into the central nervous system to create a regulatory environment to the surrounding tissue which is trophic and counter-inflammatory. We report that isolated neonatal porcine SC, administered alone in highly biocompatible microcapsules, led to diabetes prevention and reversion in the respective 88 and 81% of overtly diabetic (nonobese diabetic [NOD]) mice, with no need for additional β cell or insulin therapy. The effect was associated with restoration of systemic immune tolerance and detection of functional pancreatic islets that consisted of glucose-responsive and insulin-secreting cells. Curative effects by SC were strictly dependent on efficient tryptophan metabolism in the xenografts, leading to TGF-β–dependent emergence of autoantigen-specific regulatory T cells and recovery of β cell function in the diabetic recipients.

15 November 2009 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
Francesca FallarinoFrancesca Fallarino
Francesca Fallarino
CVClaudia Volpi
Claudia Volpi
TERESA ZELANTETERESA ZELANTE
TERESA ZELANTE
CVCarmine Vacca
Carmine Vacca
MCMario Calvitti
Mario Calvitti
UGUrsula Grohmann
Ursula Grohmann
Originally predicated on the recognition of an increasing prevalence of allergy, the hygiene hypothesis was later found to accommodate the contrasting epidemiologic trends in developed countries for infectious vs autoimmune diseases. Experimentally, reduced exposure to infections will increase the risk of disease in several models of experimental autoimmunity. Although TLRs were initially considered as stimulatory molecules capable of activating early defense mechanisms against invading pathogens, emerging data suggest that they can also exert a regulatory function. In the present study, we evaluated whether TLR3 and TLR9, recognizing microbial dsDNA and CpG-containing DNA sequences, respectively, play a role in the protection from experimental autoimmune diabetes induced in C57BL/6 mice by streptozotocin. In wild-type animals, the disease was accompanied by up-regulation of IDO in pancreatic lymph nodes and would be greatly exacerbated by in vivo administration of an IDO inhibitor. Conversely, administration of a CpG-containing oligodeoxynucleotide greatly attenuated the disease in an IDO-dependent fashion. TLR9-, but not TLR3-deficient mice developed a more robust disease, an event accompanied by lack of IDO induction in pancreatic lymph nodes. Thus, our data suggest that the TLR9-IDO axis may represent a valuable target in the prevention/therapy of type 1 diabetes.